Position in AZN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$207,556,724
+$202,625,238 QoQ
Shares Held
1,094,593
+4277.5% QoQ
Ownership
0.071%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#97
of 1,457 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026D. E. Shaw & Co., Inc. holds $2,890,989,313 across 13 Drug Manufacturers - General names. AZN ranks #6 (7.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
496,563 | $595,592,608 | |
| 2 | ABBV |
AbbVie Inc.
|
2,102,316 | $529,026,797 | |
| 3 | AMGN |
Amgen Inc
|
1,290,217 | $467,213,379 | |
| 4 | MRK |
Merck & Co., Inc.
|
2,738,023 | $351,835,955 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
2,294,789 | $289,923,642 | |
| 6 | AZN |
Astrazeneca PLC
This page
|
1,094,593 | $207,556,724 | |
| 7 | JNJ |
Johnson & Johnson
|
687,227 | $174,535,041 | |
| 8 | PFE |
Pfizer Inc
|
5,414,297 | $130,376,270 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $207,556,724 | 1,094,593 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $4,931,486 | 25,005 | Shares | Defined | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||